Author: Seth, Gaurav; Sethi, Saira; Bhattarai, Shristi; Saini, Geetanjali; Singh, Chandra Bhushan; Aneja, Ritu
Title: SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis Cord-id: eypn6qgb Document date: 2020_11_5
ID: eypn6qgb
Snippet: SIMPLE SUMMARY: Cancer patients are a highly vulnerable subgroup in this coronavirus disease 2019 (COVID-19) pandemic. This crisis has dramatically disrupted the continuous care provided to cancer patients, as well as diagnostic and therapeutic procedures. Thus, studies that help gain insights into COVID-19 prevalence, disease severity, prognosis, and clinical outcomes in cancer patients are of great importance. In this review, we outline the current knowledge of disease outcomes and prognoses f
Document: SIMPLE SUMMARY: Cancer patients are a highly vulnerable subgroup in this coronavirus disease 2019 (COVID-19) pandemic. This crisis has dramatically disrupted the continuous care provided to cancer patients, as well as diagnostic and therapeutic procedures. Thus, studies that help gain insights into COVID-19 prevalence, disease severity, prognosis, and clinical outcomes in cancer patients are of great importance. In this review, we outline the current knowledge of disease outcomes and prognoses for cancer patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and learn if the severity is exacerbated by cancer type, anticancer therapies, gender, behavioral risk factors (e.g., smoking, alcohol consumption), and comorbidities. Our article will help clinicians determine cases where treatment can be postponed during the pandemic and will encourage further research to better understand the impact of SARS-CoV-2 infection on cancer patients. ABSTRACT: The severity of coronavirus disease 2019 (COVID-19) symptoms and outcomes vary immensely among patients. Predicting disease progression and managing disease symptoms is even more challenging in cancer patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Cancer therapies, including chemotherapy, radiotherapy, and immunotherapy, often suppress the immune system, rendering cancer patients more susceptible to SARS-CoV-2 infection and the development of severe complications. However, data on the effects of immunosuppression on COVID-19 outcomes in cancer patients remain limited. Further investigations are warranted to better understand the implications of SARS-CoV-2 infection in cancer patients, particularly those that are immunocompromised. In this review, we outline the current knowledge of the effects of SARS-CoV-2 infection in cancer patients.
Search related documents:
Co phrase search for related documents- acute kidney injury and additional study: 1, 2, 3
- acute kidney injury and adjuvant chemotherapy: 1
- acute kidney injury and long term effect: 1
- acute kidney injury and low antibody: 1
- acute kidney injury and lung breast: 1
- acute kidney injury and lung breast cancer: 1
- acute kidney injury and lung cancer: 1, 2, 3, 4, 5, 6, 7
- acute kidney injury and lung cancer patient: 1
- acute kidney injury and lung endothelial: 1, 2
- acute kidney injury and lung failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute kidney injury and lung failure acute: 1, 2, 3, 4, 5
- acute kidney injury and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8
- acute kidney injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- acute kidney injury and lung injury cause: 1
- acute kidney injury and lung tissue: 1, 2, 3, 4, 5, 6, 7
- acute kidney injury and lung tissue damage: 1
- acute kidney injury and lymph node: 1, 2
- acute kidney injury and magnetic resonance: 1, 2, 3, 4, 5, 6, 7
- acute kidney injury sepsis and lung injury: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date